drug

sodium phenylbutyrate

1 story · latest Aug 5, 2026

Status: FDA approved Jun 2022 · NDA214860, NDA216513
Brands: Olpruva, Pheburane

Timeline

Zevra reports Q2 2026 results as MIPLYFFA revenue grows and EU review continues

Aug 5Quarterly updatearimoclomol Zevra Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.